Global Prophylactic Human Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Prophylactic Human Vaccine market size was valued at USD 198.6 million in 2023 and is forecast to a readjusted size of USD 263.4 million by 2030 with a CAGR of 4.1% during review period.
Vaccination in the body of a healthy person causes the person to produce antibodies and obtain specific immunity in the absence of disease. For example, BCG vaccination, smallpox vaccination and so on.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Prophylactic Human Vaccine industry chain, the market status of Hospital (Inactivated Vaccine, Attenuated Vaccine), Scientific Research (Inactivated Vaccine, Attenuated Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Prophylactic Human Vaccine.
Regionally, the report analyzes the Prophylactic Human Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Prophylactic Human Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Prophylactic Human Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Prophylactic Human Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Inactivated Vaccine, Attenuated Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Prophylactic Human Vaccine market.
Regional Analysis: The report involves examining the Prophylactic Human Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Prophylactic Human Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Prophylactic Human Vaccine:
Company Analysis: Report covers individual Prophylactic Human Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Prophylactic Human Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Scientific Research).
Technology Analysis: Report covers specific technologies relevant to Prophylactic Human Vaccine. It assesses the current state, advancements, and potential future developments in Prophylactic Human Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Prophylactic Human Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Prophylactic Human Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Prophylactic Human Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prophylactic Human Vaccine, with price, sales, revenue and global market share of Prophylactic Human Vaccine from 2019 to 2024.
Chapter 3, the Prophylactic Human Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prophylactic Human Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Prophylactic Human Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prophylactic Human Vaccine.
Chapter 14 and 15, to describe Prophylactic Human Vaccine sales channel, distributors, customers, research findings and conclusion.
Vaccination in the body of a healthy person causes the person to produce antibodies and obtain specific immunity in the absence of disease. For example, BCG vaccination, smallpox vaccination and so on.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Prophylactic Human Vaccine industry chain, the market status of Hospital (Inactivated Vaccine, Attenuated Vaccine), Scientific Research (Inactivated Vaccine, Attenuated Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Prophylactic Human Vaccine.
Regionally, the report analyzes the Prophylactic Human Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Prophylactic Human Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Prophylactic Human Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Prophylactic Human Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Inactivated Vaccine, Attenuated Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Prophylactic Human Vaccine market.
Regional Analysis: The report involves examining the Prophylactic Human Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Prophylactic Human Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Prophylactic Human Vaccine:
Company Analysis: Report covers individual Prophylactic Human Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Prophylactic Human Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Scientific Research).
Technology Analysis: Report covers specific technologies relevant to Prophylactic Human Vaccine. It assesses the current state, advancements, and potential future developments in Prophylactic Human Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Prophylactic Human Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Prophylactic Human Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Inactivated Vaccine
- Attenuated Vaccine
- Others
- Hospital
- Scientific Research
- Others
- GSK
- Biovac
- McKesson Medical
- Merck
- Merial
- Zoetis
- Sanofi
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Prophylactic Human Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prophylactic Human Vaccine, with price, sales, revenue and global market share of Prophylactic Human Vaccine from 2019 to 2024.
Chapter 3, the Prophylactic Human Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prophylactic Human Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Prophylactic Human Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prophylactic Human Vaccine.
Chapter 14 and 15, to describe Prophylactic Human Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Prophylactic Human Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Prophylactic Human Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Inactivated Vaccine
1.3.3 Attenuated Vaccine
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Prophylactic Human Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Scientific Research
1.4.4 Others
1.5 Global Prophylactic Human Vaccine Market Size & Forecast
1.5.1 Global Prophylactic Human Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Prophylactic Human Vaccine Sales Quantity (2019-2030)
1.5.3 Global Prophylactic Human Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Prophylactic Human Vaccine Product and Services
2.1.4 GSK Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments/Updates
2.2 Biovac
2.2.1 Biovac Details
2.2.2 Biovac Major Business
2.2.3 Biovac Prophylactic Human Vaccine Product and Services
2.2.4 Biovac Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biovac Recent Developments/Updates
2.3 McKesson Medical
2.3.1 McKesson Medical Details
2.3.2 McKesson Medical Major Business
2.3.3 McKesson Medical Prophylactic Human Vaccine Product and Services
2.3.4 McKesson Medical Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 McKesson Medical Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Prophylactic Human Vaccine Product and Services
2.4.4 Merck Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck Recent Developments/Updates
2.5 Merial
2.5.1 Merial Details
2.5.2 Merial Major Business
2.5.3 Merial Prophylactic Human Vaccine Product and Services
2.5.4 Merial Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Merial Recent Developments/Updates
2.6 Zoetis
2.6.1 Zoetis Details
2.6.2 Zoetis Major Business
2.6.3 Zoetis Prophylactic Human Vaccine Product and Services
2.6.4 Zoetis Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Zoetis Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Prophylactic Human Vaccine Product and Services
2.7.4 Sanofi Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sanofi Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PROPHYLACTIC HUMAN VACCINE BY MANUFACTURER
3.1 Global Prophylactic Human Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Prophylactic Human Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Prophylactic Human Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Prophylactic Human Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Prophylactic Human Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Prophylactic Human Vaccine Manufacturer Market Share in 2023
3.5 Prophylactic Human Vaccine Market: Overall Company Footprint Analysis
3.5.1 Prophylactic Human Vaccine Market: Region Footprint
3.5.2 Prophylactic Human Vaccine Market: Company Product Type Footprint
3.5.3 Prophylactic Human Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Prophylactic Human Vaccine Market Size by Region
4.1.1 Global Prophylactic Human Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Prophylactic Human Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Prophylactic Human Vaccine Average Price by Region (2019-2030)
4.2 North America Prophylactic Human Vaccine Consumption Value (2019-2030)
4.3 Europe Prophylactic Human Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Prophylactic Human Vaccine Consumption Value (2019-2030)
4.5 South America Prophylactic Human Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Prophylactic Human Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Prophylactic Human Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Prophylactic Human Vaccine Consumption Value by Type (2019-2030)
5.3 Global Prophylactic Human Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Prophylactic Human Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Prophylactic Human Vaccine Consumption Value by Application (2019-2030)
6.3 Global Prophylactic Human Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Prophylactic Human Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Prophylactic Human Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Prophylactic Human Vaccine Market Size by Country
7.3.1 North America Prophylactic Human Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Prophylactic Human Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Prophylactic Human Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Prophylactic Human Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Prophylactic Human Vaccine Market Size by Country
8.3.1 Europe Prophylactic Human Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Prophylactic Human Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Prophylactic Human Vaccine Market Size by Region
9.3.1 Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Prophylactic Human Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Prophylactic Human Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Prophylactic Human Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Prophylactic Human Vaccine Market Size by Country
10.3.1 South America Prophylactic Human Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Prophylactic Human Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Prophylactic Human Vaccine Market Size by Country
11.3.1 Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Prophylactic Human Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Prophylactic Human Vaccine Market Drivers
12.2 Prophylactic Human Vaccine Market Restraints
12.3 Prophylactic Human Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Prophylactic Human Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prophylactic Human Vaccine
13.3 Prophylactic Human Vaccine Production Process
13.4 Prophylactic Human Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Prophylactic Human Vaccine Typical Distributors
14.3 Prophylactic Human Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Prophylactic Human Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Prophylactic Human Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Inactivated Vaccine
1.3.3 Attenuated Vaccine
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Prophylactic Human Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Scientific Research
1.4.4 Others
1.5 Global Prophylactic Human Vaccine Market Size & Forecast
1.5.1 Global Prophylactic Human Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Prophylactic Human Vaccine Sales Quantity (2019-2030)
1.5.3 Global Prophylactic Human Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Prophylactic Human Vaccine Product and Services
2.1.4 GSK Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments/Updates
2.2 Biovac
2.2.1 Biovac Details
2.2.2 Biovac Major Business
2.2.3 Biovac Prophylactic Human Vaccine Product and Services
2.2.4 Biovac Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biovac Recent Developments/Updates
2.3 McKesson Medical
2.3.1 McKesson Medical Details
2.3.2 McKesson Medical Major Business
2.3.3 McKesson Medical Prophylactic Human Vaccine Product and Services
2.3.4 McKesson Medical Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 McKesson Medical Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Prophylactic Human Vaccine Product and Services
2.4.4 Merck Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck Recent Developments/Updates
2.5 Merial
2.5.1 Merial Details
2.5.2 Merial Major Business
2.5.3 Merial Prophylactic Human Vaccine Product and Services
2.5.4 Merial Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Merial Recent Developments/Updates
2.6 Zoetis
2.6.1 Zoetis Details
2.6.2 Zoetis Major Business
2.6.3 Zoetis Prophylactic Human Vaccine Product and Services
2.6.4 Zoetis Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Zoetis Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Prophylactic Human Vaccine Product and Services
2.7.4 Sanofi Prophylactic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sanofi Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PROPHYLACTIC HUMAN VACCINE BY MANUFACTURER
3.1 Global Prophylactic Human Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Prophylactic Human Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Prophylactic Human Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Prophylactic Human Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Prophylactic Human Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Prophylactic Human Vaccine Manufacturer Market Share in 2023
3.5 Prophylactic Human Vaccine Market: Overall Company Footprint Analysis
3.5.1 Prophylactic Human Vaccine Market: Region Footprint
3.5.2 Prophylactic Human Vaccine Market: Company Product Type Footprint
3.5.3 Prophylactic Human Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Prophylactic Human Vaccine Market Size by Region
4.1.1 Global Prophylactic Human Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Prophylactic Human Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Prophylactic Human Vaccine Average Price by Region (2019-2030)
4.2 North America Prophylactic Human Vaccine Consumption Value (2019-2030)
4.3 Europe Prophylactic Human Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Prophylactic Human Vaccine Consumption Value (2019-2030)
4.5 South America Prophylactic Human Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Prophylactic Human Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Prophylactic Human Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Prophylactic Human Vaccine Consumption Value by Type (2019-2030)
5.3 Global Prophylactic Human Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Prophylactic Human Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Prophylactic Human Vaccine Consumption Value by Application (2019-2030)
6.3 Global Prophylactic Human Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Prophylactic Human Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Prophylactic Human Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Prophylactic Human Vaccine Market Size by Country
7.3.1 North America Prophylactic Human Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Prophylactic Human Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Prophylactic Human Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Prophylactic Human Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Prophylactic Human Vaccine Market Size by Country
8.3.1 Europe Prophylactic Human Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Prophylactic Human Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Prophylactic Human Vaccine Market Size by Region
9.3.1 Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Prophylactic Human Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Prophylactic Human Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Prophylactic Human Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Prophylactic Human Vaccine Market Size by Country
10.3.1 South America Prophylactic Human Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Prophylactic Human Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Prophylactic Human Vaccine Market Size by Country
11.3.1 Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Prophylactic Human Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Prophylactic Human Vaccine Market Drivers
12.2 Prophylactic Human Vaccine Market Restraints
12.3 Prophylactic Human Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Prophylactic Human Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prophylactic Human Vaccine
13.3 Prophylactic Human Vaccine Production Process
13.4 Prophylactic Human Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Prophylactic Human Vaccine Typical Distributors
14.3 Prophylactic Human Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Prophylactic Human Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Prophylactic Human Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Prophylactic Human Vaccine Product and Services
Table 6. GSK Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GSK Recent Developments/Updates
Table 8. Biovac Basic Information, Manufacturing Base and Competitors
Table 9. Biovac Major Business
Table 10. Biovac Prophylactic Human Vaccine Product and Services
Table 11. Biovac Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Biovac Recent Developments/Updates
Table 13. McKesson Medical Basic Information, Manufacturing Base and Competitors
Table 14. McKesson Medical Major Business
Table 15. McKesson Medical Prophylactic Human Vaccine Product and Services
Table 16. McKesson Medical Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. McKesson Medical Recent Developments/Updates
Table 18. Merck Basic Information, Manufacturing Base and Competitors
Table 19. Merck Major Business
Table 20. Merck Prophylactic Human Vaccine Product and Services
Table 21. Merck Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Merck Recent Developments/Updates
Table 23. Merial Basic Information, Manufacturing Base and Competitors
Table 24. Merial Major Business
Table 25. Merial Prophylactic Human Vaccine Product and Services
Table 26. Merial Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Merial Recent Developments/Updates
Table 28. Zoetis Basic Information, Manufacturing Base and Competitors
Table 29. Zoetis Major Business
Table 30. Zoetis Prophylactic Human Vaccine Product and Services
Table 31. Zoetis Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Zoetis Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Prophylactic Human Vaccine Product and Services
Table 36. Sanofi Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sanofi Recent Developments/Updates
Table 38. Global Prophylactic Human Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 39. Global Prophylactic Human Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 40. Global Prophylactic Human Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 41. Market Position of Manufacturers in Prophylactic Human Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 42. Head Office and Prophylactic Human Vaccine Production Site of Key Manufacturer
Table 43. Prophylactic Human Vaccine Market: Company Product Type Footprint
Table 44. Prophylactic Human Vaccine Market: Company Product Application Footprint
Table 45. Prophylactic Human Vaccine New Market Entrants and Barriers to Market Entry
Table 46. Prophylactic Human Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Prophylactic Human Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 48. Global Prophylactic Human Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 49. Global Prophylactic Human Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 50. Global Prophylactic Human Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 51. Global Prophylactic Human Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 52. Global Prophylactic Human Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 53. Global Prophylactic Human Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 54. Global Prophylactic Human Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 55. Global Prophylactic Human Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Global Prophylactic Human Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Global Prophylactic Human Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 58. Global Prophylactic Human Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 59. Global Prophylactic Human Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 60. Global Prophylactic Human Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 61. Global Prophylactic Human Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Global Prophylactic Human Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Global Prophylactic Human Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 64. Global Prophylactic Human Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 65. North America Prophylactic Human Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 66. North America Prophylactic Human Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 67. North America Prophylactic Human Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 68. North America Prophylactic Human Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 69. North America Prophylactic Human Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 70. North America Prophylactic Human Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 71. North America Prophylactic Human Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 72. North America Prophylactic Human Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Europe Prophylactic Human Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Europe Prophylactic Human Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Europe Prophylactic Human Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 76. Europe Prophylactic Human Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 77. Europe Prophylactic Human Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 78. Europe Prophylactic Human Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 79. Europe Prophylactic Human Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Prophylactic Human Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 82. Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 83. Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 84. Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 85. Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 86. Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 87. Asia-Pacific Prophylactic Human Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 88. Asia-Pacific Prophylactic Human Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 89. South America Prophylactic Human Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 90. South America Prophylactic Human Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 91. South America Prophylactic Human Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 92. South America Prophylactic Human Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 93. South America Prophylactic Human Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 94. South America Prophylactic Human Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 95. South America Prophylactic Human Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America Prophylactic Human Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 98. Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 99. Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 102. Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 103. Middle East & Africa Prophylactic Human Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Middle East & Africa Prophylactic Human Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 105. Prophylactic Human Vaccine Raw Material
Table 106. Key Manufacturers of Prophylactic Human Vaccine Raw Materials
Table 107. Prophylactic Human Vaccine Typical Distributors
Table 108. Prophylactic Human Vaccine Typical Customers
Table 1. Global Prophylactic Human Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Prophylactic Human Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Prophylactic Human Vaccine Product and Services
Table 6. GSK Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GSK Recent Developments/Updates
Table 8. Biovac Basic Information, Manufacturing Base and Competitors
Table 9. Biovac Major Business
Table 10. Biovac Prophylactic Human Vaccine Product and Services
Table 11. Biovac Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Biovac Recent Developments/Updates
Table 13. McKesson Medical Basic Information, Manufacturing Base and Competitors
Table 14. McKesson Medical Major Business
Table 15. McKesson Medical Prophylactic Human Vaccine Product and Services
Table 16. McKesson Medical Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. McKesson Medical Recent Developments/Updates
Table 18. Merck Basic Information, Manufacturing Base and Competitors
Table 19. Merck Major Business
Table 20. Merck Prophylactic Human Vaccine Product and Services
Table 21. Merck Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Merck Recent Developments/Updates
Table 23. Merial Basic Information, Manufacturing Base and Competitors
Table 24. Merial Major Business
Table 25. Merial Prophylactic Human Vaccine Product and Services
Table 26. Merial Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Merial Recent Developments/Updates
Table 28. Zoetis Basic Information, Manufacturing Base and Competitors
Table 29. Zoetis Major Business
Table 30. Zoetis Prophylactic Human Vaccine Product and Services
Table 31. Zoetis Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Zoetis Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Prophylactic Human Vaccine Product and Services
Table 36. Sanofi Prophylactic Human Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sanofi Recent Developments/Updates
Table 38. Global Prophylactic Human Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 39. Global Prophylactic Human Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 40. Global Prophylactic Human Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 41. Market Position of Manufacturers in Prophylactic Human Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 42. Head Office and Prophylactic Human Vaccine Production Site of Key Manufacturer
Table 43. Prophylactic Human Vaccine Market: Company Product Type Footprint
Table 44. Prophylactic Human Vaccine Market: Company Product Application Footprint
Table 45. Prophylactic Human Vaccine New Market Entrants and Barriers to Market Entry
Table 46. Prophylactic Human Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Prophylactic Human Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 48. Global Prophylactic Human Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 49. Global Prophylactic Human Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 50. Global Prophylactic Human Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 51. Global Prophylactic Human Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 52. Global Prophylactic Human Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 53. Global Prophylactic Human Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 54. Global Prophylactic Human Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 55. Global Prophylactic Human Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Global Prophylactic Human Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Global Prophylactic Human Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 58. Global Prophylactic Human Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 59. Global Prophylactic Human Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 60. Global Prophylactic Human Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 61. Global Prophylactic Human Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Global Prophylactic Human Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Global Prophylactic Human Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 64. Global Prophylactic Human Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 65. North America Prophylactic Human Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 66. North America Prophylactic Human Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 67. North America Prophylactic Human Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 68. North America Prophylactic Human Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 69. North America Prophylactic Human Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 70. North America Prophylactic Human Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 71. North America Prophylactic Human Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 72. North America Prophylactic Human Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Europe Prophylactic Human Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Europe Prophylactic Human Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Europe Prophylactic Human Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 76. Europe Prophylactic Human Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 77. Europe Prophylactic Human Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 78. Europe Prophylactic Human Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 79. Europe Prophylactic Human Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Prophylactic Human Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 82. Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 83. Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 84. Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 85. Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 86. Asia-Pacific Prophylactic Human Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 87. Asia-Pacific Prophylactic Human Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 88. Asia-Pacific Prophylactic Human Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 89. South America Prophylactic Human Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 90. South America Prophylactic Human Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 91. South America Prophylactic Human Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 92. South America Prophylactic Human Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 93. South America Prophylactic Human Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 94. South America Prophylactic Human Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 95. South America Prophylactic Human Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America Prophylactic Human Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 98. Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 99. Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 102. Middle East & Africa Prophylactic Human Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 103. Middle East & Africa Prophylactic Human Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Middle East & Africa Prophylactic Human Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 105. Prophylactic Human Vaccine Raw Material
Table 106. Key Manufacturers of Prophylactic Human Vaccine Raw Materials
Table 107. Prophylactic Human Vaccine Typical Distributors
Table 108. Prophylactic Human Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Prophylactic Human Vaccine Picture
Figure 2. Global Prophylactic Human Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Prophylactic Human Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Inactivated Vaccine Examples
Figure 5. Attenuated Vaccine Examples
Figure 6. Others Examples
Figure 7. Global Prophylactic Human Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Prophylactic Human Vaccine Consumption Value Market Share by Application in 2023
Figure 9. Hospital Examples
Figure 10. Scientific Research Examples
Figure 11. Others Examples
Figure 12. Global Prophylactic Human Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Prophylactic Human Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Prophylactic Human Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Prophylactic Human Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Prophylactic Human Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Prophylactic Human Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Prophylactic Human Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Prophylactic Human Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Prophylactic Human Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Prophylactic Human Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Prophylactic Human Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Prophylactic Human Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Prophylactic Human Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Prophylactic Human Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Prophylactic Human Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Prophylactic Human Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Prophylactic Human Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Prophylactic Human Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Prophylactic Human Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Prophylactic Human Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Prophylactic Human Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Prophylactic Human Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Prophylactic Human Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Prophylactic Human Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Prophylactic Human Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Prophylactic Human Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Prophylactic Human Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Prophylactic Human Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Prophylactic Human Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Prophylactic Human Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Prophylactic Human Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Prophylactic Human Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Prophylactic Human Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Prophylactic Human Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Prophylactic Human Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Prophylactic Human Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Prophylactic Human Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Prophylactic Human Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Prophylactic Human Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Prophylactic Human Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Prophylactic Human Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Prophylactic Human Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Prophylactic Human Vaccine Market Drivers
Figure 75. Prophylactic Human Vaccine Market Restraints
Figure 76. Prophylactic Human Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Prophylactic Human Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Prophylactic Human Vaccine
Figure 80. Prophylactic Human Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Prophylactic Human Vaccine Picture
Figure 2. Global Prophylactic Human Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Prophylactic Human Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Inactivated Vaccine Examples
Figure 5. Attenuated Vaccine Examples
Figure 6. Others Examples
Figure 7. Global Prophylactic Human Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Prophylactic Human Vaccine Consumption Value Market Share by Application in 2023
Figure 9. Hospital Examples
Figure 10. Scientific Research Examples
Figure 11. Others Examples
Figure 12. Global Prophylactic Human Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Prophylactic Human Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Prophylactic Human Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Prophylactic Human Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Prophylactic Human Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Prophylactic Human Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Prophylactic Human Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Prophylactic Human Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Prophylactic Human Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Prophylactic Human Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Prophylactic Human Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Prophylactic Human Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Prophylactic Human Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Prophylactic Human Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Prophylactic Human Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Prophylactic Human Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Prophylactic Human Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Prophylactic Human Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Prophylactic Human Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Prophylactic Human Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Prophylactic Human Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Prophylactic Human Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Prophylactic Human Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Prophylactic Human Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Prophylactic Human Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Prophylactic Human Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Prophylactic Human Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Prophylactic Human Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Prophylactic Human Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Prophylactic Human Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Prophylactic Human Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Prophylactic Human Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Prophylactic Human Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Prophylactic Human Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Prophylactic Human Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Prophylactic Human Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Prophylactic Human Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Prophylactic Human Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Prophylactic Human Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Prophylactic Human Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Prophylactic Human Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Prophylactic Human Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Prophylactic Human Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Prophylactic Human Vaccine Market Drivers
Figure 75. Prophylactic Human Vaccine Market Restraints
Figure 76. Prophylactic Human Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Prophylactic Human Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Prophylactic Human Vaccine
Figure 80. Prophylactic Human Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
